29th Annual EuroMeeting

Patients, healthcare providers, and society as a whole benefit from innovation in the pharmaceutical sector. The patients benefit by potentially gaining access to new and efficient medications. The healthcare providers benefit by being able to provide/choose between different treatment options. Ultimately society benefits by having healthier population with potentially better quality of life. Pharmaceutical research and development is a long and expensive process, therefore, appropriate incentives and appropriate regulatory framework need to be in place for creating and maintaining an environment for innovation. During the session we will explore what could be the role of venture capitalists, regulators and health insurance systems in building the right incentives and regulatory framework to support innovation which will ultimately benefit the patients, health care providers and society as a whole.